T_reg Lymphocytes in Autoimmune Uveitis

REFERENCES

• Caspi RR. Immune mechanism in uveitis. Springer Semin Immunopathol. 1999; 21:113–124.
   PubMed Web of Science ®Google Scholar
• Redpath S, Ghazal P, Gascoigne NR. Hijacking: exploration of IL-10 by intracellular pathogens. Trend Microbiol. 2001; 9: 86–92.
   PubMed Web of Science ®Google Scholar
• Reed SG. TGF-β in infections and infectious diseases. Microbes infect. 1999; 1: 1313–1325.
   PubMed Web of Science ®Google Scholar
• Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F. Thymic regulatory T cells. Autoimmun Rev. 2005; 4:579–586.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, . Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Op Immunol. 2005; 7:638–642.
   Google Scholar
• Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999; 189:877–882.
   PubMed Web of Science ®Google Scholar
• Sakagushi S. Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non self. Nat Immunol. 2005; 6: 345–352.
   PubMed Web of Science ®Google Scholar
• Fontenot JP, Ruensky AY. A well adapted regulatory contrivance: regulatory T cell development and forkhead family transcription factor FoxP3. Nat Immunol. 2005; 6: 331–337.
   PubMed Web of Science ®Google Scholar
• Bennet CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001; 27: 20–21.
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001; 27: 68–73.
   PubMed Web of Science ®Google Scholar
• Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity. 1997; 7: 445–450.
   PubMed Web of Science ®Google Scholar
• Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol. 1997; 158: 1989–1993.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting Interleukin 2 production. J Exp Med. 1998;188:287–296.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140 (3):509–516.
   PubMed Web of Science ®Google Scholar
• Khairallah M. Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm. 2010 Jan;18 (1):2–4.
   PubMed Web of Science ®Google Scholar
• Chen L. Yang P, Zhou H, et al. Decreased frequency and diminished function of CD4+ CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalm Vis Sci. 2008; 49 (8): 3475–3482.
   PubMed Web of Science ®Google Scholar
• Hamazaoui K, Hamazaoui A, Houman H. CD4+CD25+ regulatory T cells in patients with Behcet's disease. Clin Exp Rheumatol. 2006; 24(5)(suppl 42): 571–578.
   Web of Science ®Google Scholar
• Yeh S, Li Z, Forooghian F, et al. CD4+ FoxP3+ T-regulatory cells in noninfectious uveitis. Arch Ophthalmol. 2009 Apr;127 (4):407–413.
   PubMedGoogle Scholar
• Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol. 2008;18 (4):354–358.
   PubMed Web of Science ®Google Scholar
• Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FoxP3-mutant human T cells: FoxP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A. 2006;103: 6659–6664.
   PubMed Web of Science ®Google Scholar
• Roncador G, Brown PJ, Maestre L, et al. Analysis of FoxP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol. 2005;35: 1681–1691.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995 Aug 1;155 (3):1151–1164.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998 Dec;10 (12):1969–1980.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:83–190.
   Web of Science ®Google Scholar
• Roncarolo AM, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev. 2001;182:68–79.
   PubMed Web of Science ®Google Scholar
• Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol. 2008;38 (4):921–924.
   PubMed Web of Science ®Google Scholar
• Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3 (11):619–626.
   PubMedGoogle Scholar
• Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+CD25+FoxP3+ regulatory T cells. Immunol Rev. 2006;212:60–73..
   PubMed Web of Science ®Google Scholar
• Keino H, Takeuchi M, Usui Y, et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91 (1):105–110..
   PubMed Web of Science ®Google Scholar
• Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996 Aug 1;184 (2):387–396.
   PubMed Web of Science ®Google Scholar
• Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999 May 1; 162 (9):5317–5326.
   PubMed Web of Science ®Google Scholar